Stratipath brings together physicians, researchers, AI-scientists, developers and industry specialists in its mission to help all patients get the right treatment through precision diagnostics.

Stratipath is a spin-out from Karolinska Institutet in Stockholm, Sweden, bringing pioneering research from the fields of artificial intelligence (AI) and precision medicine into clinical use. The company was founded in 2019 with a mission to radically improve cancer treatment decisions and patient outcomes.

Stratipath uses AI technology and research to improve cancer diagnostics for more patients. Today far too many patients receive inconclusive cancer diagnoses and have unequal access to precision diagnostics. Stratipath’s AI technology can change this by providing patients with faster access to novel, more conclusive and precise results, at a sustainable cost.